How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?

Eur Urol. 2017 May;71(5):838-840. doi: 10.1016/j.eururo.2017.01.043. Epub 2017 Feb 8.

¹ Turku Centre for Biotechnology, Turku, Finland; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
² Turku Centre for Biotechnology, Turku, Finland; Department of Information Technology, University of Turku, Turku, Finland.
³ Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland.
⁴ Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland; Department of Clinical Oncology, University of Turku, Turku, Finland.
⁵ Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital and University of Turku, Turku, Finland; Centre for Clinical Informatics, Turku University Hospital, Turku, Finland.
⁶ Turku Centre for Biotechnology, Turku, Finland. Electronic address: laura.elo@utu.fi.

No abstract available

Publication types